Cargando…
Personalized treatment options for thyroid cancer: current perspectives
Thyroid cancer is one of the most common endocrine malignancies, with increasing incidence all over the world. In spite of good prognosis for differentiated thyroid carcinoma, for an unknown reason, about 5–10% of the patients, the cancer will show aggressive behavior, develop metastasis, and be ref...
Autores principales: | Khatami, Fatemeh, Larijani, Bagher, Nikfar, Shekoufeh, Hasanzad, Mandana, Fendereski, Kiarad, Tavangar, Seyed Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750856/ https://www.ncbi.nlm.nih.gov/pubmed/31571972 http://dx.doi.org/10.2147/PGPM.S181520 |
Ejemplares similares
-
Precision Medicine in Non Communicable Diseases
por: Hasanzad, Mandana, et al.
Publicado: (2019) -
Circulating Tumor BRAF Mutation and Personalized Thyroid Cancer Treatment
por: Khatami, Fatemeh, et al.
Publicado: (2017) -
Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations
por: Khatami, Fatemeh, et al.
Publicado: (2019) -
Oncometabolites as biomarkers in thyroid cancer: a systematic review
por: Khatami, Fatemeh, et al.
Publicado: (2019) -
The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream
por: Hasanzad, Mandana, et al.
Publicado: (2019)